J Pediatr Infect Dis 2024; 19(02): 083-088
DOI: 10.1055/s-0043-1777335
Original Article

Comparison of Clinical, Laboratory Parameters, and Outcome of COVID-19-Positive and Negative Neonates Delivered from COVID-19-Positive Mothers

Preeti Singh
1   Department of Pediatrics, Baba Raghav Das Medical College, Gorakhpur, Uttar Pradesh, India
Ankur Kumar
2   Department of Microbiology, Baba Raghav Das Medical College, Gorakhpur, Uttar Pradesh, India
1   Department of Pediatrics, Baba Raghav Das Medical College, Gorakhpur, Uttar Pradesh, India
Mudit Chauhan
3   Department of Social and Preventive Medicine, Baba Raghav Das Medical College, Gorakhpur, Uttar Pradesh, India
› Institutsangaben
Funding None.


Objective Severe acute respiratory syndrome coronavirus 2 is a highly contagious respiratory viral infection that affects all individuals, although neonates are considered to be the most susceptible populations; therefore, this study was conducted to evaluate the clinical outcome and association between coronavirus disease 2019 (COVID-19)-positive mothers and newborns.

Methods This cross-sectional study was conducted at a dedicated COVID-19 tertiary care hospital in India over a period of 1 year. The pregnant mothers infected with COVID-19 virus were enrolled with their newborn baby up to the age of 28 days. COVID-19 test was done by using a rapid antigen kit and further confirmed by reverse-transcription polymerase chain reaction.

Results Prevalence of COVID-19-positive newborns born of COVID-19-positive mothers is reported at 8.4%. Female:male ratio was found to be 1:1.2. Raised D-dimer (88.9%) and C-reactive protein (88.9%) were the most common findings in COVID-19-positive newborns followed by leucopenia (33.3%). Among the COVID-19 newborns, Apgar score less than or equal to 7 and respiratory distress were found in 55.6 and 33.3%, respectively. Out of 9 COVID-19-positive newborns, two (22.2%) were expired, and out of 98 COVID-19-negative newborns, 4(4.1%) were expired.

Conclusion This study revealed that severity of maternal symptoms is related to mortality of newborns. About 22.2% COVID-19-positive newborns expired, whereas 4.1% of COVID-19-negative newborns expired so risk of mortality increased among COVID-19-positive neonates as compared with negative ones. However, this study was conducted on a small sample size and further research with larger populations is needed to validate these findings.


Eingereicht: 12. Juli 2023

Angenommen: 17. Oktober 2023

Artikel online veröffentlicht:
29. Dezember 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

  • References

  • 1 Chawla D, Chirla D, Dalwai S. et al; Federation of Obstetric and Gynaecological Societies of India (FOGSI), National Neonatology Forum of India (NNF) and Indian Academy of Pediatrics (IAP). Perinatal-Neonatal Management of COVID-19 Infection - Guidelines of the Federation of Obstetric and Gynaecological Societies of India (FOGSI), National Neonatology Forum of India (NNF), and Indian Academy of Pediatrics (IAP). Indian Pediatr 2020; 57 (06) 536-548
  • 2 Rood M, Ten Kate L, Boeddha NP, van 't Kruys K. Clinical characteristics, transmission rate and outcome of neonates born to COVID-19-positive mothers: a prospective case series from a resource-limited setting. Pediatr Infect Dis J 2023; 42 (01) 35-42
  • 3 Anand P, Yadav A, Debata P, Bachani S, Gupta N, Gera R. Clinical profile, viral load, management and outcome of neonates born to COVID 19 positive mothers: a tertiary care centre experience from India. Eur J Pediatr 2021; 180 (02) 547-559
  • 4 He J, Guo Y, Mao R, Zhang J. Proportion of asymptomatic coronavirus disease 2019: a systematic review and meta-analysis. J Med Virol 2021; 93 (02) 820-830
  • 5 Maria A, Singh BK, Agrawal P, Bandyopadhyay T. A short-term follow-up study on breastfeeding practices, growth parameters and immunization practices among babies born to COVID-19 positive mothers in a tertiary care hospital. J Trop Pediatr 2022; 69 (01) fmad006
  • 6 Husen MF, van der Meeren LE, Verdijk RM. et al. Unique severe covid-19 placental signature independent of severity of clinical maternal symptoms. Viruses 2021; 13 (08) 1670
  • 7 Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 2002; 9 (03) 147-160
  • 8 Doctor PN, Kamat D, Sood BG. Changes in clinical care of the newborn during COVID-19 pandemic: from the womb to first newborn visit. Pediatr Clin North Am 2021; 68 (05) 1055-1070
  • 9 Bharti LK. Standard Treatment Guidelines 2022; Neonatal Resuscitation Program. Indian Academy of Pediatrics (IAP) 2022. Accessed November 2, 2023 at: https://iapindia.org/pdf/Ch-104-Neonatal-Resuscitation-Program.pdf
  • 10 Kshatri JS, Giri S, Bhattacharya D. et al. Analysis of the COVID-19 testing parameters and progression of the pandemic at the district level: findings from the ICMR Hundred Million Test (HMT) database during the first wave in India. Int J Infect Dis 2022; 122: 497-505
  • 11 Malik S, Jain D, Bokade CM. et al. Outcomes in neonates born to mothers with COVID-19 during the second wave in India. Eur J Pediatr 2022; 181 (09) 3537-3543
  • 12 Smith V, Seo D, Warty R. et al. Maternal and neonatal outcomes associated with COVID-19 infection: a systematic review. PLoS One 2020; 15 (06) e0234187
  • 13 Cai J, Tang M, Gao Y. et al. Cesarean section or vaginal delivery to prevent possible vertical transmission from a pregnant mother confirmed with COVID-19 to a neonate: a systematic review. Front Med (Lausanne) 2021; 8: 634949
  • 14 Panda SK, Mishra A, Pathak M. Clinical outcome of neonates born to SARS-CoV-2 positive mothers in India: a systematic review and meta-analysis. Cureus 2022; 14 (03) e22958
  • 15 Sankaranarayanan P, Shanmuganathan H, Kumar D, Nair L, Kamalakannan S. Multisystem inflammatory syndrome-neonate: biochemical parameters as early marker of adverse neurodevelopmental outcome. Open J Pediatr 2022; 12: 767-782
  • 16 Jafari M, Pormohammad A, Sheikh Neshin SA. et al. Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: a systematic review and meta-analysis. Rev Med Virol 2021; 31 (05) 1-16
  • 17 Villar J, Ariff S, Gunier RB. et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID Multinational Cohort Study. JAMA Pediatr 2021; 175 (08) 817-826